Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

Market Cap	2.25B +4.3%
Revenue (ttm)	344.12M +3.9%
Net Income	-41.07M
EPS	-0.17
Shares Out	239.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,564,300
Open	9.46
Previous Close	9.38
Day's Range	9.17 - 9.46
52-Week Range	9.15 - 15.25
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:000590

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offers prescription and over-the-counter drugs, such as tonics, cardiovascular drugs, children's nutritional supplements, cold and flu remedies, and heat-cl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1956
• Employees: 1,064
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000590

Financial Performance

In 2025, SHE:000590's revenue was 337.67 million, a decrease of -1.61% compared to the previous year's 343.21 million. Losses were -50.52 million, -59.74% less than in 2024.